Chronic Kidney Disease Management
Definition and Classification
- Chronic kidney disease (CKD) is defined based on estimated glomerular filtration rate (eGFR) and albuminuria, with the UK guidelines categorizing renal impairment as mild (eGFR 60-89 ml/min/1.73 m²), moderate (eGFR 30-59 ml/min/1.73 m²), and severe (eGFR 15-29 ml/min/1.73 m²) 1
- The CKD staging system combines five GFR categories (G1-G5) and three albuminuria categories (A1-A3), with a patient's classification reported as a combination of both (e.g., CKD G3aA2), as supported by the National Kidney Foundation and the European Society of Cardiology 1, 2, 3, 4
Diagnosis and Evaluation
- Patients with eGFR <60 ml/min/1.73 m² should be evaluated for complications of CKD, including hypertension, early anemia, mineral and bone disorders, and metabolic acidosis, as recommended by the National Kidney Foundation and the Kidney International guidelines 5, 6, 7, 8, 9
- The MDRD 4-variable equation is widely recommended for estimating GFR, calculating it as 186 × (SCr)^-1.154 × (age)^-0.203 × (0.742 if female) × (1.21 if Black-American), and is preferred for eGFR reporting due to its validation in diverse populations, as stated by the National Kidney Foundation and the European Society of Cardiology 10, 3, 4, 11
- The Cockcroft-Gault equation is another method for estimating GFR, considering age, sex, and body weight, with the formula: GFR = [(140 - age) × weight (kg) × 0.85 if female] / [72 × serum creatinine (mg/dL)], although it tends to overestimate GFR in CKD stages 3-5, as reported by the American College of Physicians 12, 13, 4
CKD Staging and Monitoring
- GFR values can be broken down into stages:
- The CKD severity can be staged using GFR (G1-G5), with the following stages:
- The frequency of GFR monitoring depends on individual health conditions, with recommendations ranging from at least once a year to 1-4 times per year depending on severity, as recommended by the Kidney International guidelines and the American College of Physicians 6, 7, 8, 9, 15
Treatment and Management
- ACE inhibitors or ARBs are strongly recommended for patients with severely increased albuminuria (≥300 mg/g creatinine) or eGFR <60 mL/min/1.73 m², as supported by the Kidney International guidelines and the National Kidney Foundation 7, 6
- SGLT2 inhibitors are recommended when eGFR ≥30 mL/min/1.73 m², according to the Kidney International guidelines and the American College of Physicians 14, 13
- Controlling blood pressure, diabetes, and staying well-hydrated can help maintain kidney health, as recommended by Kidney International and the European Heart Journal 6, 4
- Consider other markers of kidney damage, such as albuminuria, hematuria, and structural abnormalities, to verify kidney disease, and the National Kidney Foundation recommends confirming the finding with repeat testing within 3 months to establish chronicity 16, 15
Recommendations for Specific Populations
| Population | Intervention | Outcome | Recommendation |
|---|---|---|---|
| Patients with GFR <90 mL/min/1.73m² | Use MDRD formula | More accurate estimate of GFR | National Kidney Foundation [15] |
| Elderly patients | Calculate creatinine clearance | Accurate assessment of renal function | American College of Physicians [13] |
| Patients with chronic kidney disease | Regular monitoring of creatinine clearance | Tracking disease progression | American College of Physicians [15] |
| Elderly cancer patients | Calculate creatinine clearance | Accurate assessment of renal function | [13] |
- The risk of cardiovascular disease increases with mild levels of kidney dysfunction, and hypertension should be carefully managed in patients with CKD, as reported by the European Heart Journal and the European Society of Cardiology 4